NY-DILIGENT
Diligent Corporation today unveiled the Diligent Institute , a groundbreaking think tank dedicated to filling a void for today’s board directors around a global perspective on governance.
At its core, Diligent Institute provides board directors and executive teams with industry-leading global research on governance practices to better inform decision-making, enabling organizations to drive increased environmental and social impact and long-term value. With access to more boardrooms than any company in the world, Diligent is uniquely situated to share the collective knowledge of this community to improve governance practices worldwide.
This announcement comes amidst a year full of innovation from Diligent and demonstrates the company’s continued investment in empowering the state of global corporate governance. The new research arm offers board directors consequential perspectives from today’s top minds to better inform the decisions and strategies that propel business success.
“As the leader in Governance software, we took it upon ourselves to give back to the global community of board directors with the creation of Diligent Institute,” said Diligent CEO Brian Stafford. “What’s important for a boardroom today differs from years past. This one-of-a-kind organization equips leaders with game-changing information and research, giving them the tools to make more insightful, strategic decisions that drive their businesses forward.”
Diligent’s global reach sets the Institute’s research apart and is derived from real experience across sectors and geographies. Through its quantitative surveys, case studies, and interviews with leading professionals and experts, the Institute improves the transparency, accountability, and efficiency of businesses world-wide. The Institute has already provided insight from a global panel of board directors on many pressing board service questions from their peers in the Ask a Director series. The Institute has also assembled an Advisory Board with a membership spanning industries and geographies. The advisory board members offer a distinct perspective to guide the Institute. They include:
- Anastassia Lauterbach, Director on the Boards of Dun & Bradstreet, Wirecard, and Censhare, a senior advisor to McKinsey and Company, and the author of The Artificial Intelligence Imperative: A Practical Roadmap for Business
- David Larcker, James Irvin Miller Professor of Accounting and Director of the Corporate Governance Research Initiative at the Stanford Graduate School of Business
- Dottie Schindlinger, Vice President and Governance Technology Evangelist at Diligent Corporation, co-author of forthcoming Governance in the Digital Age, renowned speaker on Governance issues, and a founder of BoardEffect.
- Peter Gleason , President and CEO of the National Association of Corporate Directors
- Susan Kilsby , Chairman of Shire plc. and Non-Executive Director of Diageo, Goldman Sachs International, Fortune Brand Home & Security, and BBA Aviation
- Susan Forrester , Director on the Boards of G8 Education Ltd, Over the Wire, and Xenith IP Group, as well as Chairman of National Veterinary Care Ltd.
- TK Kerstetter, Founder and CEO of Boardroom Resources, Editor-at-Large of Corporate Board Member , and Host of “Inside America’s Boardrooms”
- Brian Stafford , CEO of Diligent Corporation and co-author of forthcoming Governance in the Digital Age
“Diligent Institute targets the global issues that face today’s boardrooms,” said Anastassia Lauterbach, a Diligent Institute advisory board member. “It is getting increasingly hard to address corporate competitiveness and grow the value of businesses in the age of rising Artificial Intelligence, global worries about inequality, and confusion around the impact of data on our lives and decision making. Diligent Institute provides a fantastic platform to educate boards on use cases, best practices, and support directors in the decision-making process.”
Diligent Institute is the global governance research arm of Diligent Corporation, whose corporate governance products are used by more than 500,000 individuals in 14,000 organizations across 90 countries. It will operate separately from the company’s core business. The research is free and is available at DiligentInstitute.com .
About Diligent Institute
Diligent Institute was founded in 2018 to offer a global perspective on the complex and disruptive board governance topics that directors and leadership teams are tackling today. The Institute serves as the global governance research arm of Diligent Corporation, the leading Enterprise Governance Management provider of secure corporate governance and collaboration solutions for boards and senior executives. The Diligent Institute is solely funded by the Diligent Corporation.
About Diligent
Diligent is the leading Enterprise Governance Management provider of secure corporate governance and collaboration solutions for boards and senior executives. Over 14,000 clients in more than 90 countries and on all seven continents rely on Diligent for secure distribution of board materials, as well as secure messaging, integrated compliance, board evaluation and entity management. Governance Cloud is the only solution that meets the evolving governance needs of leading organizations. Visit www.diligent.com to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181205005043/en/
Contact:
For Diligent Corporation Greg Nyhan, 646-215-6884 gnyhan@mww.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AwardFares Launches Intelligent New Alert System for Award Flight Availability5.8.2025 08:00:00 CEST | Press release
AwardFares, the leading search platform for award flights, today launched a major upgrade to its alert system, giving users smarter tools to discover and book award availability faster. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804412041/en/ AwardFares' Timeline view provides a clear, color-coded visualization of daily award seat availability across different cabin classes, helping users easily spot trends and opportunities for flights. The new system includes two powerful features: Flex Alerts and Live Alerts. Together, they provide both flexibility and precision, helping travelers maximize their points and miles like never before. Flex Alerts are designed for the flexible traveler. Instead of requiring an exact route and date, users can set broad criteria such as "any airport in the US to Europe for an entire month.” AwardFares' AI-powered system intelligently identifies matching availability, focusing not just on
Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy5.8.2025 02:02:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) received approval from the U.S. Department of Energy (DOE) for an uprate amendment to its Calcasieu Pass LNG project. The uprate approval increases Calcasieu Pass’ permitted peak liquefaction capacity from 12.0 million tonnes per annum (MTPA) to 12.4 MTPA. “Venture Global thanks its regulators, including DOE, for their efforts in prioritizing and streamlining approvals for critical energy infrastructure projects. These multibillion dollar investments will be key as the United States strengthens global energy security and increases energy trade with our partners around the world,” said Venture Global CEO Mike Sabel. Calcasieu Pass, Venture Global’s first project, reached first LNG production in 2022 and began commercial operations in April 2025. The company’s second facility, Plaquemines LNG, began LNG production in December 2024. Venture Global’s third project, CP2, received DOE export authorization and FERC approval in March 2025 and May 2025, re
Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain4.8.2025 22:01:00 CEST | Press release
– Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint –– Treatment with VX-993 was generally safe and well tolerated, with safety profile similar to placebo arm – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced topline results from its recently completed Phase 2, randomized, double-blind, placebo-controlled dose-ranging study evaluating the safety and efficacy of its investigational selective NaV1.8 pain signal inhibitor, VX-993, in treating acute pain after bunionectomy surgery. Treatment with VX-993 did not result in a statistically significant improvement on the primary endpoint of the time-weighted Sum of the Pain Intensity Difference from 0 to 48 hours (SPID48) compared to placebo. VX-993 was generally safe and well tolerated. Most adverse events (AEs) were mild to moderate, and there were no serious adverse events (SAEs) related to VX-993. Based on these results, Vertex will not progress
TOURISE Announces Cross-Sector Advisory Board to Champion Bold New Platform Rewriting the Rules of Tourism4.8.2025 20:53:00 CEST | Press release
Leaders from World Travel & Tourism Council (WTTC), Global Sustainable Tourism Council, Amadeus, TikTok, Six Senses, Cirque du Soleil, Turismede Barcelona, Liberty International, Wagonlit Travel, Once Billion Happy, the Saudi Tourism Authority (STA), and the Riyadh School of Tourism and Hospitality at the helm of TOURISE Advisory Board Formation of the Advisory Board reinforces TOURISE’s dedication to driving cross-sector global collaboration Advisory Board shape TOURISE summit agenda, ensuring high-impact global issues such as equity, geographical representation and sectoral diversity are in spotlight TOURISE, the bold new global tourism platform, has announced the members of its cross-sector Advisory Board, a powerhouse of industry titans guiding TOURISE’s strategic direction and shaping the agenda of the inaugural global summit taking place in Riyadh from 11-13 November, 2025. TOURISE is where cross-sector convergence begins, a platform where leaders and visionaries debate, collabor
Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe4.8.2025 20:38:00 CEST | Press release
Concept Medical Inc., a global pioneer in drug-delivery technologies, announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels) trial, a U.S. Investigational Device Exemption (IDE) study evaluating its MagicTouch™ sirolimus-coated balloon (SCB) for the treatment of small coronary vessels. This first U.S. enrollment follows the FDA’s IDE approval of MagicTouch SCB, marking a major milestone in Concept Medical’s mission to revolutionize coronary artery disease (CAD) treatment and expand its clinical program into the US and Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250804524652/en/ Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Study Dr. Samin Sharma enrolled the first patient at New York’s Mount Sinai Hospital, Director of Interventional Cardiology, marking a crucial step in advancing treatm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom